QCM
NVAX icon

Quantinno Capital Management’s Novavax NVAX Stock Holding History

Quantinno Capital Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$288K Buy
35,359
+12,304
+53% +$112K ﹤0.01% 3053
2025
Q4 		$155K Sell
23,055
-3,412
-13% -$25.7K ﹤0.01% 3089
2025
Q3 		$229K Buy
26,467
+8,869
+50% +$69K ﹤0.01% 2666
2025
Q2 		$111K Buy
+17,598
New +$117K ﹤0.01% 2494

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Quantinno Capital Management's NVAX Position: Q1 2026 in Review

Quantinno Capital Management increased its Novavax (NVAX) stake by 53% in Q1 2026, buying an estimated $112K and bringing the position to 35,359 shares worth $288K. The position accounts for ﹤0.01% of the portfolio, ranked #3053.

Quantinno Capital Management first reported a position in NVAX in Q2 2025 and has held it in 4 quarters since. 257 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • Quantinno Capital Management held 35,359 shares of Novavax worth $288K as of Q1 2026.
  • Quantinno Capital Management bought 12,304 Novavax shares in Q1 2026, an estimated $112K.
  • Novavax made up ﹤0.01% of Quantinno Capital Management's portfolio in Q1 2026, its #3053 holding.
  • Quantinno Capital Management first reported a position in Novavax in Q2 2025 and has held it in 4 quarters since.
  • 257 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.